Announcement on Abnormal Fluctuations in Stock Trading
Filed with SSE · · 3 pages · Chinese
Kexing Biopharm Co., Ltd. on 6ix
Earlier from Kexing Biopharm
- Announcement on the Progress of Proposed Transfer of Equity of Wholly-owned Subsidiary
- Indicative Announcement on Change in Shareholder and Persons Acting in Concert's Equity Reaching an Integer Multiple of 5%
- Kexing Biopharm's GB18 project received clearance of IND application from NMPA and FDA
Later from Kexing Biopharm
- Kexing Biopharm Makes Its Debut at CPHI 2025, Followed by the 2025 International Pharmaceutical Cooperation High-End Forum, One of the Kexing Biopharm's Series of Globalization Activities in Shanghai
- Announcement on Shareholding Changes Reaching 1% Threshold, Completion of Shareholding Reduction Plan and Results of Shares Sold
- Announcement on Vesting Results and Share Listing in the 1st Vesting Period of the 2024 Restricted Stock Incentive Plan
- Announcement on General Election of Board of Directors
- Indicative Announcement on Report on Results of Shareholders' Inquiry Transfer and Equity Change of Shareholders with Over 5% Shares Reaching 1% Integer Multiple
Follow Kexing Biopharm into a list and get an email when it puts out news.
Follow Kexing Biopharm